Nektar Therapeutics | Markedsværdi

Market Capitalization Lave om Dato
Agios Pharmaceuticals USD 1.25B 135M 2023-12
ALKERMES USD 4.63B 36M 2023-12
Alterity Therapeutics Limited USD 11M 5M 2023-06
Amgen USD 154.14B 10.38B 2023-12
Baxter International USD 19.61B 501M 2023-12
BioCryst Pharmaceuticals USD 1.23B 115M 2023-12
Biogen USD 37.5B 274M 2023-12
Bluebird Bio USD 325M 25M 2023-09
Bristol-Myers Squibb USD 104.4B 16.85B 2023-12
Cara Therapeutics USD 41M 50M 2023-12
Cipla INR 1.01T 48.59B 2023-12
Dr.Reddys Laboratories INR 965.43B 35.54B 2023-12
Eisai JPY 2.09T 376.18B 2023-12
Eli Lilly USD 731.69B 178.32B 2024-03
Esperion Therapeutics USD 340M 235M 2023-12
Exelixis USD 7.46B 503M 2023-12
Gilead Sciences USD 100.94B 7.57B 2023-12
GlaxoSmithKline GBP 59.68B 1.42B 2023-12
Grifols USD 10.31B 2.38B 2023-12
Halozyme Therapeutics USD 4.88B 157M 2023-12
Incyte USD 12.89B 1.18B 2024-03
Ionis Pharmaceuticals USD 6.19B 1.07B 2024-03
Ironwood Pharmaceuticals USD 1.37B 416M 2024-03
Merck USD 314.33B 38.07B 2024-03
Nektar Therapeutics USD 113M 4M 2023-09
Neurocrine Biosciences USD 14.28B 1.33B 2024-03
Novartis CHF 193.29B 20.5B 2023-12
Pfizer USD 155.51B 7.05B 2024-03
Roche Holding CHF 199.67B 23.81B 2023-12
Sarepta Therapeutics USD 11.76B 2.73B 2024-03
Takeda JPY 6.42T 928.65B 2023-12
Teva Pharmaceutical Industries ILS 42.76B 315.46M 2023-12
Xencor USD 1.37B 81M 2024-03



Nektar Therapeutics Markedsværdi - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Apr 2024.